发明名称 |
CONTINUOUS ADMINISTRATION OF CILENGITIDE IN CANCER TREATMENTS |
摘要 |
<p>The invention relates to a combination therapy for the treatment of tumors and tumor metastases comprising the continuous administration of integrin ligands, preferably integrin antagonists, together with co-therapeutic agent or therapy forms that have synergistic efficacy when administered consecutively with said ligands, such as chemotherapeutic agents and or radiation therapy.</p> |
申请公布号 |
SG176103(A1) |
申请公布日期 |
2011.12.29 |
申请号 |
SG20110084381 |
申请日期 |
2010.05.25 |
申请人 |
MERCK PATENT GMBH |
发明人 |
PICARD, MARTIN, ANDREAS;BETHE, ULLRICH;DOTZAUER, MATTHIAS;MOYAL, ELIZABETH, COHEN-JONATHAN |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|